VPI-131

N/A

Report date: 2025/01/26 15:58:09

Base Information

Drug NameVPI-131
Drug Alias NameIL17-VaultVPI-131
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInterleukin-17 agonists
TargetsInterleukin-17
Therapy Area/IndicationsPulmonary FibrosisLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesVault Pharma Inc
Inactive CompaniesN/A
Active IndicationsPulmonary FibrosisLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A